XML 62 R45.htm IDEA: XBRL DOCUMENT v3.24.1

Commitments and Contingencies (Details Narrative)											2 Months Ended	12 Months Ended
	Sep. 26, 2023 USD ($)	Jun. 22, 2023 USD ($)	Apr. 17, 2023 USD ($)	Nov. 06, 2022 USD ($)	Jun. 10, 2022 USD ($)	May 01, 2021 USD ($)	Feb. 05, 2021 USD ($)	Aug. 20, 2018 USD ($)	Sep. 14, 2015 USD ($)	Dec. 24, 2013 USD ($)	Aug. 31, 2020 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Oct. 03, 2023 USD ($)	Oct. 03, 2023 EUR (€)	Oct. 08, 2021 EUR (€)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Contractual commitment												$ 6,412,000
Research and developments costs												898,100	$ 1,349,269
Aggregate commitments expected												6,013,000
Eric J. Forman [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Compensation				$ 200,000
Payment of office rent												1,500
Officer [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Compensation												700,000
GEIS [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Amount related to milestone payment												684,652
NDA Consulting Corp [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Consulting and advisory fee										$ 4,000		16,000	16,000
Clinical Trial Agreements [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Contractual commitment												6,013,000
Clinical Trial Monitoring Agreements [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Contractual commitment												399,000
Clinical Research Support Agreement [Member] | City of Hope [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Research and developments costs												69,001	0
Total costs incurred												447,512
Aggregate commitments expected												2,433,000
Estimated additional commitment amount												800,000
Collaboration Agreement [Member] | GEIS [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Research and developments costs												268,829	260,770
Aggregate commitments expected												3,580,000
Inventory costs												1,144,000
Collaboration Agreement [Member] | Bio Pharma Works LLC [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Consulting and advisory fee									$ 10,000
Reimbursed expense												120,000	120,000
Clinical Trial Research Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Research and developments costs												16,165	26,397
Aggregate commitments expected												147,239
Work Order Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total costs incurred												14,862
Aggregate commitments expected												141,000
Work Order Agreement [Member] | City of Hope [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Research and developments costs							$ 335,000					20,240	33,815
Total costs incurred												78,681
Aggregate commitments expected												258,000
Work Order Agreement [Member] | Moffitt Cancer Center and Research Institute Hospital Inc [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Research and developments costs												20,884	35,403
Total costs incurred												148,172
Work Order Agreement [Member] | Theradex Systems, Inc. [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Research and developments costs												14,862
Work cost		$ 153,000
Percentage of payment through services		72.00%
Percentage of payment through software		28.00%
Exclusive License Agreement [Member] | Moffitt Cancer Center and Research Institute Hospital Inc [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Non refundable license issue fee								$ 25,000
Maintenance fee								25,000
Payment on non refundable milestone								$ 1,897,000
Operating costs and expenses												9,109	25,000
Employment Agreement [Member] | Executive Officers [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Annual compensation						$ 775,000					$ 640,000
Employment Agreement [Member] | Eric J. Forman [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Payment of office rent												15,571	937
Employment Agreement [Member] | Bastiaan Van Der Baan [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Compensation	$ 150,000
Development Collaboration Agreement [Member] | Netherlands Cancer Institute [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Research and developments costs												226,150	204,158
Total costs incurred												485,556
Aggregate commitments expected												595,000		$ 526,000	€ 500,000	€ 391,000
MRI Global [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Research and developments costs												32,307	$ 27,702
Total costs incurred												248,298
Aggregate commitments expected												$ 78,000
Contract price			$ 326,274		$ 273,980

X

- Definition

Amount related to milestone payment.

+ References

No definition available.

+ Details

Name:	LIXT_AmountRelatedToMilestonePayment
Namespace Prefix:	LIXT_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Company is obligated to pay annual license maintenance fee.

+ References

No definition available.

+ Details

Name:	LIXT_AnnualLicenseMaintenanceFee
Namespace Prefix:	LIXT_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Consulting and advisory quarterly cash fee.

+ References

No definition available.

+ Details

Name:	LIXT_ConsultingAndAdvisoryCashFee
Namespace Prefix:	LIXT_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Contract price.

+ References

No definition available.

+ Details

Name:	LIXT_ContractPrice
Namespace Prefix:	LIXT_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Estimated additional commitment.

+ References

No definition available.

+ Details

Name:	LIXT_EstimatedAdditionalCommitment
Namespace Prefix:	LIXT_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Estimated work cost.

+ References

No definition available.

+ Details

Name:	LIXT_EstimatedWorkCost
Namespace Prefix:	LIXT_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Percentage of expected paymen through software.

+ References

No definition available.

+ Details

Name:	LIXT_ExpectedPaymentThroughSoftware
Namespace Prefix:	LIXT_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Expected payment in services.

+ References

No definition available.

+ Details

Name:	LIXT_ExpectedPaymentinServices
Namespace Prefix:	LIXT_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Company is obligated to pay non refundable license issue fee..

+ References

No definition available.

+ Details

Name:	LIXT_NonRefundableLicenseIssueFee
Namespace Prefix:	LIXT_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Company agreed to pay non-refundable milestone payments which cannot be credited against earned royalties payable by the Company, based on reaching various clinical and commercial milestones.

+ References

No definition available.

+ Details

Name:	LIXT_PaymentsOnNonrefundableMilestone
Namespace Prefix:	LIXT_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Reimbursement expense.

+ References

No definition available.

+ Details

Name:	LIXT_ReimbursementExpense
Namespace Prefix:	LIXT_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479402/808-10-50-1

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount of contractual obligation, including, but not limited to, long-term debt, lease obligation, purchase obligation, and other commitments.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3

+ Details

Name:	us-gaap_ContractualObligation
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(17))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(10))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1

+ Details

Name:	us-gaap_DeferredCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Amount of expense for employee benefit and equity-based compensation.

+ References

No definition available.

+ Details

Name:	us-gaap_EmployeeBenefitsAndShareBasedCompensation
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date for elements of machinery or equipment held for the purpose of replacing similar parts in the course of repair or maintenance.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(6)(a))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 5.BB)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480581/330-10-S99-2

+ Details

Name:	us-gaap_InventoryPartsAndComponentsNetOfReserves
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(4))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

+ Details

Name:	us-gaap_OfficersCompensation
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.

+ References

No definition available.

+ Details

Name:	us-gaap_OperatingCostsAndExpenses
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.

+ References

No definition available.

+ Details

Name:	us-gaap_OtherCommitment
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Cash payments to lessor's for use of assets under operating leases.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 25
-Subparagraph (g)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-25

+ Details

Name:	us-gaap_PaymentsForRent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 730
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482916/730-10-50-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 912
-SubTopic 730
-Name Accounting Standards Codification
-Section 25
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482517/912-730-25-1

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481283/985-20-50-1

+ Details

Name:	us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Details

Name:	srt_TitleOfIndividualAxis=LIXT_EricJFormanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_TitleOfIndividualAxis=srt_OfficerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LIXT_GrupoEspanolDeInvestigacionEnSarcomasMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LIXT_NDAConsultingCorpMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=LIXT_ClinicalTrialAgreementsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=LIXT_ClinicalTrialMonitoringAgreementsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=LIXT_ClinicalResearchSupportAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	dei_LegalEntityAxis=LIXT_CityOfHopeNationalMedicalCenterMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=LIXT_CollaborationAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=LIXT_BioPharmaWorksLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=LIXT_ClinicalTrialResearchAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=LIXT_WorkOrderAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	dei_LegalEntityAxis=LIXT_MoffittCancerCenterandResearchInstituteHospitalIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	dei_LegalEntityAxis=LIXT_TheradexSystemsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=LIXT_ExclusiveLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=LIXT_EmploymentAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_TitleOfIndividualAxis=LIXT_ExecutiveOfficersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_TitleOfIndividualAxis=LIXT_BastiaanVanDerBaanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=LIXT_DevelopmentCollaborationAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	dei_LegalEntityAxis=LIXT_NetherlandsCancerInstituteMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=LIXT_MRIGlobalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: